跳至主要内容
临床试验/NCT00268294
NCT00268294已完成不适用

Restoring Sinus Rhythm With Cardiac Resynchronization in Patients With Atrial Fibrillation

Medtronic Cardiac Rhythm and Heart Failure2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2003年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
2
主要终点
To compare the AF burden, frequency and duration of episodes when atrial therapies are ON vs. OFF.

研究概览

简要总结

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy may be prescribed.

People who have a dangerously fast heart beat, or whose heart is at risk of stopping beating, may be in need of an electronic device called an implantable cardioverter defibrillator (ICD).

Atrial tachyarrhythmia (AT) is the name for rapid beats in the upper chambers of the heart. People with AT may experience symptoms such as heart palpitations (a racing or pounding feeling in the chest), shortness of breath, dizziness, fatigue or weakness.

The purpose of this study is to characterize the impact of cardiac resynchronization therapy versus cardiac resynchronization therapy with atrial therapies on the incidence, duration and termination of atrial tachyarrhythmias.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with atrial fibrillation
  • Subjects with a heart beat that is too fast and who have been determined by a doctor to require an implantable cardioverter defibrillator (ICD) i.

排除标准

  • Subjects with a natural heart rate less than 30bpm

结局指标

主要结局

To compare the AF burden, frequency and duration of episodes when atrial therapies are ON vs. OFF.

次要结局

未报告次要终点

研究者

发起方
Medtronic Cardiac Rhythm and Heart Failure
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验